News 2021 - SISAQOL

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI

2025-03-12T15:42:37+01:00

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI2025-03-12T15:42:37+01:00

Collaborating for consensus

2025-03-12T15:43:56+01:00

Collaborating for consensus2025-03-12T15:43:56+01:00

Read our systematic review on patient-reported outcomes in metastatic breast cancer

2025-03-12T15:45:16+01:00

Read our systematic review on patient-reported outcomes in metastatic breast cancer2025-03-12T15:45:16+01:00

The SISAQOL initiative during the 5th EORTC Quality of Life Conference in Brussels

2025-03-12T15:45:46+01:00

The SISAQOL initiative during the 5th EORTC Quality of Life Conference in Brussels2025-03-12T15:45:46+01:00

The SISAQOL-IMI Project received funding from the Innovative Health Initiative 2 joint undertaking under grant agreement No 945052. This Joint Undertaking (JU) received support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This publication reflects only the author’s view and the JU is not responsible for any use that may be made of the information it contains.